Operating profit margin has jumped from 17.38% to 9.52%, leading to 32.12% decline in operating profit to Rs 74.88 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 36.25% to 31.56%.   Purchase of finished goods cost rose from 0.92% to 1.67%.   Employee cost decreased from 5.96% to 5.23%.   Other expenses rose from 39.60% to 52.20%.   Selling and administration expenses rose from 6.43% to 24.22%.   

Other income fell 40.10% to Rs 5.72 crore.  PBIDT fell 32.75% to Rs 80.6 crore.  Provision for interest fell 29.81% to Rs 0.73 crore.  Loan funds remained nil.  Inventories rose to Rs 249.30 crore as of 30 June 2021 from Rs 205.05 crore as of 30 June 2020.  Sundry debtors were lower at Rs 142.35 crore as of 30 June 2021 compared to Rs 166.34 crore as of 30 June 2020.  Cash and bank balance declined from Rs 902.50 crore as of 30 June 2020 to Rs 660.24 crore as of 30 June 2021.  

PBDT fell 32.78% to Rs 79.87 crore.  Provision for depreciation down 4.39% to Rs 12.62 crore.  Fixed assets declined from Rs 228.65 crore as of 30 June 2020 to Rs 221.39 crore as of 30 June 2021.  

Profit before tax down 36.33% to Rs 67.25 crore.  Provision for tax was expense of Rs 18.27 crore, compared to Rs 36.41 crore.  Effective tax rate was 27.17% compared to 34.47%.

Profit after tax fell 29.23% to Rs 48.98 crore.  

Equity capital stood at Rs 32.46 crore as of 30 June 2021 to Rs 32.46 crore as of 30 June 2020.  Per share face Value remained same at Rs 10.00.  

Promoters' stake was 70.64% as of 30 June 2021 ,compared to 70.64% as of 30 June 2020 .  

Full year results analysis

Net sales (including other operating income) of Procter & Gamble Hygiene and Health Care has increased 19.06% to Rs 3,574.14 crore.  

Operating profit margin has jumped from 20.11% to 24.74%, leading to 46.47% rise in operating profit to Rs 884.28 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 35.29% to 31.48%.   Purchase of finished goods cost fell from 1.74% to 1.15%.   Employee cost decreased from 5.76% to 5.63%.   Other expenses fell from 37.15% to 37.07%.   Selling and administration expenses rose from 10.91% to 14.58%.   Provisions writeoffs cost fell from 0.46% to 0.21%.   Other provisions fell from 0.46% to 0.21%.   

Other income fell 10.72% to Rs 39.38 crore.  PBIDT rose 42.58% to Rs 923.66 crore.  Provision for interest up 0.66% to Rs 6.11 crore.  Loan funds remained nil.  Inventories rose to Rs 249.30 crore as of 30 June 2021 from Rs 205.05 crore as of 30 June 2020.  Sundry debtors were lower at Rs 142.35 crore as of 30 June 2021 compared to Rs 166.34 crore as of 30 June 2020.  Cash and bank balance declined from Rs 902.50 crore as of 30 June 2020 to Rs 660.24 crore as of 30 June 2021.  

PBDT rose 42.98% to Rs 917.55 crore.  Provision for depreciation down 0.46% to Rs 47.66 crore.  Fixed assets declined from Rs 228.65 crore as of 30 June 2020 to Rs 221.39 crore as of 30 June 2021.  

Profit before tax grew 46.48% to Rs 869.89 crore.  Provision for tax was expense of Rs 218.1 crore, compared to Rs 160.79 crore.  Effective tax rate was 25.07% compared to 27.07%.

Profit after tax rose 50.50% to Rs 651.79 crore.  

Equity capital stood at Rs 32.46 crore as of 30 June 2021 to Rs 32.46 crore as of 30 June 2020.  Per share face Value remained same at Rs 10.00.  

Promoters' stake was 70.64% as of 30 June 2021 ,compared to 70.64% as of 30 June 2020 .  

Cash flow from operating activities increased to Rs 863.12 crore for year ended June 2021 from Rs 473.75 crore for year ended June 2020.  Cash flow used in acquiring fixed assets during the year ended June 2021 stood at Rs 31.60 crore, compared to Rs 51.02 crore during the year ended June 2020.  

Other Highlights

The board has recommended a final dividend of Rs 80 per Equity Share for the Financial Year ended June 30, 2021.

Management commentary: Madhusudan Gopalan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, "We continue to remain focused on protecting the health and safety of our people, serving the Indian consumers with our health and hygiene products, and supporting communities in need through our relief efforts. Despite challenges posed by the pandemic, we have delivered double-digit profitable growth for the fourth consecutive quarter and for the full year. Our strategy to focus on superiority and productivity, enabled by the resilience and agility of our organization is helping us deliver balanced growth."

He further added, "We are continuing to extend our support to the communities under our COVID-19 response and relief program #PGSurakshaIndia. We recently donated INR 50 Cr towards 10 lakh vaccine doses for 5 lakh Indian citizens in partnership with state governments and local authorities. Since the outbreak of the pandemic, we have donated more than 20 lakh masks and 30 lakh Whisper sanitary pads to support frontline workers and underprivileged communities."